Founded in 2004, LifeCell International operates in Health Tech offering advanced healthcare solutions focused on stem cell and tissue storage, as well as rapid genomics testing. The company aims to t...
Funding stage:
Venture Round
Last funding:
20/09/2021
Total funding:
$42.12 Mn+
Revenue:
Investors
Employee count:
2,662
Last 90d
2,662
Last 90d
Web traffic:
184.34K
184.34K
Last 30d
Last 30d
LifeCell International: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders45
Latest Filing Date27 Jan 2026- Funding Events59
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of LifeCell International
As of 28 January 2026, LifeCell International's equity is held by 43 shareholders, with the top three being Orbimed Asia IV Mauritius Limited, Mayura Abhaya Jain, and Abhaya Kumar S.
Orbimed Asia IV Mauritius Limited holds the largest stake in LifeCell International at 54.2% as of 28 January 2026.
As of 28 January 2026, founders collectively hold 18.0% equity in LifeCell International.
As of 28 January 2026, investors collectively hold 54.3% equity in LifeCell International.
LifeCell International's ESOP pool stands at 2.1% of total equity as of 28 January 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links